Strategic Advocates’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,142
Closed -$219K 124
2024
Q2
$219K Buy
14,142
+864
+7% +$13.4K 0.09% 110
2024
Q1
$212K Buy
+13,278
New +$212K 0.08% 116